Search Results - "metastasis"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Management of the N0 neck

    Published 2017
    Table of Contents: “…Contents: Patterns of spread of oral cancer -- Prognosis with metastatic neck disease -- Risk of occult metastasis -- Predictors of metastasis -- Tumour depth -- Perineural invasion -- Imaging of the node negative neck -- Sentinel lymph node biopsy -- Survival benefits of neck dissection.…”
    Get full text
    Series
    Electronic Video
  2. 2

    Management of the N0 neck

    Published 2017
    Table of Contents: “…Contents: Patterns of spread of oral cancer -- Prognosis with metastatic neck disease -- Risk of occult metastasis -- Predictors of metastasis -- Tumour depth -- Perineural invasion -- Imaging of the node negative neck -- Sentinel lymph node biopsy -- Survival benefits of neck dissection.…”
    Get full text
    Series
    Electronic Video
  3. 3

    Management of the N0 neck

    Published 2017
    Table of Contents: “…Contents: Patterns of spread of oral cancer -- Prognosis with metastatic neck disease -- Risk of occult metastasis -- Predictors of metastasis -- Tumour depth -- Perineural invasion -- Imaging of the node negative neck -- Sentinel lymph node biopsy -- Survival benefits of neck dissection.…”
    Get full text
    Series
    Electronic Video
  4. 4

    Clinical applications of molecular imaging imaging to guide cancer therapy /

    Published 2010
    Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
    Get full text
    Series
    Electronic Video
  5. 5

    Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

    Published 2009
    Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
    Get full text
    Series
    Electronic Video
  6. 6

    Clinical applications of molecular imaging imaging to guide cancer therapy /

    Published 2010
    Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
    Get full text
    Series
    Electronic Video
  7. 7

    Clinical applications of molecular imaging imaging to guide cancer therapy /

    Published 2010
    Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
    Get full text
    Series
    Electronic Video
  8. 8

    Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

    Published 2009
    Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
    Get full text
    Series
    Electronic Video
  9. 9

    Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

    Published 2009
    Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
    Get full text
    Series
    Electronic Video